NCT03247400View on ClinicalTrials.gov

The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 1, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

April 30, 2019

Conditions
Non-segmental Vitiligo
Interventions
DRUG

1% simvastatin-acid sodium salt ointment

1% simvastatin-acid sodium salt ointment applied onto a predefined limb

DRUG

1% atorvastatin calcium salt ointment

1% atorvastatin calcium salt ointment applied onto a predefined limb

Trial Locations (1)

85094

Clinic of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University, Faculty of Medicine in Bydgoszcz, Bydgoszcz

All Listed Sponsors
lead

Nicolaus Copernicus University

OTHER

NCT03247400 - The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo | Biotech Hunter | Biotech Hunter